News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News LeverageOne Strengthens Its Integrated Technology Platform for the Brokerage Industry News MoneySimpler Launches No-Code AI Automated Trading to Simplify Retirement Planning and Social Security Benefits News WarmySender AI Outreach Lets Marketers Run Cold-Email, LinkedIn, and Instagram Outreach on Autopilot With AI Agents Such as ChatGPT and Claude News BastionGPT releases next-generation clinical document processing and OCR for its HIPAA-compliant healthcare AI platform News Telnyx Launches Edge Compute to Complete the Real-Time AI Stack News Shoucheng Holdings Invests in Unitary Quantum: Expanding from Physical AI into Quantum Computing
